Drug Type Small molecule drug |
Synonyms FS-108 |
Target |
Action inhibitors |
Mechanism HSP90 inhibitors(Heat shock 90kDa proteins inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H38N4O6 |
InChIKeySIMISWISRGUUIP-UHFFFAOYSA-N |
CAS Registry2244887-56-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | China | 12 Sep 2016 |